Recently, Violet et al. found a significant correlation between tumoral uptake on pretherapeutic 68Ga-PSMA PET and absorbed dose by the tumor, estimated on a 177Lu-PSMA-617 whole-body scan using an automated voxelized dosimetry tool [18]. The gene discussed is FOLH1; the disease is neoplasm.